jump to content

Migraine Study — Compensation $318.00

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute…

The study periods will consist of Visit 1 (Screening) where eligibility assessment and randomization of eligible subjects will occur. The Outpatient Treatment Period will last up to 60 days and Visit 2 (End of Study) will occur either within 10 days after the dose of investigational treatment is administered or the
Outpatient Treatment Period has ended.


Compensation $318.00

More Nearby Studies

Studying How Your Body Converts Food into Energy During Different Times of the Day

Paid up to $1500

Study for patients with IBS-C or IBS-D, 16 week trial with 5 office visits pays $390

Total compensation $390

We are currently pre-screening adults between the ages of 18-75 for paid clinical…

$75/visit; up to $2,025

Rosacea Clinical Research Study

$475 for completion

Your password must contain:
6 or more characters
Upper and lowercase letters
At least one number